Curriculum Vitae Eva Meisenzahl
Univ.-Prof. Dr. Eva Meisenzahl
1. Education/Training
11/1992
State Examination, Faculty of medicine, Free University of Berlin, Germany
1992-1993
Residency, Dept. Neurology, TWW Berlin, Germany
Licensed to practice medicine (‘Approbation’)
1994-1996
Dual Residency, Dept. Neuroradiology and Dept. Psychiatry, Charité Berlin, Humboldt University (HU)
1996-2003
Residency, University Hospital of Psychiatry and Psychotherapy (Director: Prof. Dr. HJ Möller) Medical Faculty LMU Munich
2. Positions and Honors
Positions and Employment
2003
Consultant in psychiatry and psychotherapy
2004 – 2016
Senior physician University Hospital of Psychiatry and Psychotherapy (Director: Prof. Dr. HJ Möller) Medical Faculty, LMU Munich
2006 - 2016
Managing senior physician of the hospital & Responsible for giving the mandatory Teaching to the faculty of Psychology in psychopathology and clinical psychiatry, LMU Munich
2006 – 2013
Manager of the entire Education & Teaching programme for all modules in the specialty Psychiatry and Psychotherapy (MeCuM, Medical Curriculum Munich, teaching offerings in the Centre for Teaching and Studies, LMU Munich
2010 – 2016
W2 Full-Professor of Psychiatry and Psychotherapy (Director: Prof. Dr. HJ Möller) member of the faculty of medicine Department of Psychiatry, LMU, Munich, Germany, unlimited contract
2015
Call to head position of director of the department of psychiatry university of Düsseldorf, HHU; Call to head position of director of the department of psychiatry university of Linz, JPU; Call to head position of director of the department of psychiatry university of Kiel,CAU.
Since 2016
Professor of Psychiatry, Chair (Director) of the Department of Psychiatry and Psychotherapy, Heinrich-Heine-University Düsseldorf, LVR-Klinikum Düsseldorf
Memberships
Member of
- German Association for Psychiatry, Psychotherapy, Psychosomatics and Neurology (DGPPN),member workgroup predictive Psychiatry & member social psychiatry
- AGNP Working Group on Neuropharmacology
- DGBP German Society of Biological Psychiatry
- LIPPS National Association of Chairs of Psychiatry
- 5. ESAS European Scientific Association on Schizophrenia and other Psychoses
- European Association of Psychiatry, member Workgroup Neuroimaging
- European Association of Neuropsychopharmacology, member Workgroup Neuroimaging
- Member of the expert group for the development of the S3-Schizophrenia Clinical Guideline (Ed. DGPPN/AWMF); contribution to the topic: Early recognition and early intervention/ focus: brain imaging
- DÄVT, German medical Sociaty in cognitive behavioral therapy, certified supervisior
- DHV, German university association
Other experience and professional memberships
- Vice President, ESAS European Scientific Association on Schizophrenia and other Psychoses
- Chairman of the Alliance against Depression Düsseldorf
- President of ELAN e.V., association for citizen assistence
- Medical Director of the psychiatric hospital LVR Düsseldorf (2016-2020)
Awards/ Honors
Patents
- Scientific Scholarship holder of the LMU Munich (2001-2003) (180.000 Euro/2 years)
- National Prize Winner of the Von Gudden Preis (2002) (5000 Euro)
- National Prize Winner of the Hormosan Prize (2008) (10.000 Euro)
- International Prize Winner of the European Prevent Prize, Association of European Psychiatry (2011) (20.000 Euro)
- Honorary appointment as Senior Research Fellow of the Bedfordshire Center for Mental Health Research, University of Cambridge (2011)
- US Patent Adaptive pattern recognition for psychosis risk modelling US20160192889A1
3. Selected peer reviewed grants
Short title | Funding institution | Start/End | Applicants | Total funding [€] |
---|---|---|---|---|
Personalised Prognostic Tools for Early Psychosis Management” (PRONIA) | EU 7th Framework | 07/13 -onging | PI Meisenzahl, Koordinator Koutsouleris | 6 Mio. Euro |
Suicide Prevention Risk Management Alliance / Suizid Präventions-Risikomanagement Allianz: Development of an E Health Teaching programme (SUPRIMA) |
German Ministry of Health | 10/17-ongoinig | PI Meisenzahl |
676.838 |
4. Selection of peer-reviewed publications
Title | |
---|---|
Multi-modal Workflows for Psychosis Prediction in Clinical High-Risk Syndromes and Recent-Onset Depression: A Multi-Site Machine Learning Analysis. | Last author, JAMA Psychiatry, accepted IF: 17.472 |
Neuroanatomical pattern classification identifies subjects in at risk mental state of psychosis and predicts disease transition. | First author, Archives of General Psychiatry 2009, 66 (7): 700-712. (FA equally contributed) IF: 16.642 |
Plexin B3 is genetically associated with verbal performance and white matter volume in brain. | First author, Molecular Psychiatry 2007, 12 (2): 190-194. IF: 10.009 |
Brain Derived Neurotrophic Factor Val66met and Serotonin Transporter Promoter Region Polymorphisms are differently associated with reduced hippocampal volumes in major depression. | Last Author, Archives of General Psychiatry 2007, 64:410 – 416. (FA equally contributed) IF: 15.976 |
Depression-related long-term Decline of Brain Morphology: Stress-toxicity? | Last author, Archives of General Psychiatry 2008, 65(10):1156-65. IF: 15.976 |
Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers. | First author, Brain 2015. 138:2059-73 IF: 10.226 . (FA equally contributed) |
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. | Last author, Mol Psychiatry 2008, 13(12):1093-101. IF: 12.537 |
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. | Last author, Schizophr Bull 2012, 38(6):1200-15. IF: 8.486 |
Distinguishing Prodromal From First-Episode Psychosis Using Neuroanatomical Single-Subject Pattern Recognition. | Last author, Schizophr Bull 2012 38(5):11-18 IF: 8.486 |
Accelerated Brain Aging in Schizophrenia and Beyond: A Neuroanatomical Marker of Psychiatric Disorders. | Last author, Schiz Bulletin 2014, 40(5):1140-53 IF: 8.486 |
Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: A multi- modal, multisite machine learning analysis. | Middle author, JAMA Psychiatry 2018, 75(11):1156-1172. IF: 17.472 |